throbber
BIOCHEMICAL
`ENGINEERING
`FUNDAMENTALS
`
`James E. Bailey
`Professor of Chemical Engineering
`University of Houston
`
`David F. Ollis
`Associate Professor of Chemical Engineering
`Princeton University
`
`McGRAW-HILL BOOK COMPANY
`
`New York St. Louis San Francisco Auckland Bogota Dusseldorf
`Johannesburg London Madrid Mexico Montreal New Delhi Panama
`Paris Sao Paulo Singapore Sydney Tokyo Toronto
`
`.
`
`'
`-~
`
`Akermin, Inc.
`Exhibit 1020
`Page 1
`
`

`

`BIOCHEMICAL ENGINEERING FUNDAMENTALS
`
`Copyright © 1977 by McGraw-Hill, Inc. All rights reserved.
`Printed in the United States of America. No part of this publication
`may be reproduced, stored in a retrieval system, or transmitted, in any
`form or by any means, electronic, mechanical, photocopying, recording, or
`otherwise, without the prior written permission of the publisher.
`
`890 KPKP 83
`
`This book was set in Times New Roman. The editors were B. J. Clark,
`Barbara Tokay, and James W. Bradley; the cover was designed by
`Nicholas Krenitsky: the production supervisor was Charles Hess.
`The drawings were done by J & R Services. Inc.
`Kingsport Press, Inc .. was printer and binder.
`
`Library of Congress Cataloging in Publication Data
`
`Bailey, James Edwin, date
`Biochemical engineering fundamentals.
`(McGraw-Hill series in water resources and environmental engineering)
`(McGraw-Hill chemical engineering series)
`Includes index.
`I. Ollis, David F., joint author.
`1. Biochemical engineering.
`TP248.3.B34
`660'.63
`76-40006
`ISBN 0-07-003210-6
`
`II. Title.
`
`Akermin, Inc.
`Exhibit 1020
`Page 2
`
`

`

`176 BIOCHEMICAL ENGINEERING FUNDAMENTALS
`
`Azso
`
`As1o
`
`Chymotrypsinogen
`
`As4o
`
`0.75
`
`0.50
`
`0.25
`
`Thyroglobulin
`
`Eo
`'<j- 0
`«;tO
`II r l
`Cl
`:::..
`
`0
`
`Glucose
`
`1J
`1:::
`c
`"'
`-;
`>.
`"'
`
`1:::
`..<::
`p..
`
`0.75
`
`Cytochrome C
`
`0.50
`
`0.25
`
`54
`
`77
`
`123
`100
`Effluent volume. ml
`
`146
`
`I 71
`
`Figure 4.15 Chromatogram resulting from molecular-sieve chromatography of a solute mixture
`(packing is 6 percent cross-linked desulfated agar. Buffer is pH 7.5, 0.05 M tris-HCl). (Reprinted
`by permission from J. Porath, Chromatographic Methods in Fractionation of Enzymes, in L. B. Wingard,
`Jr. (ed.), "Enzyme Engineering," p. 154, John Wiley & Sons, New York, 1972.)
`
`needed to ensure protein stability, for example) the composition of the dialysate
`fluid in which the dialysis bag containing the sample is placed must be such that
`no finite concentration difference of these particular dialyzable components exists
`across the dialysis membrane, e.g., the use of w- 3 M phosphate buffer as dialy(cid:173)
`sate in step 7 of Example 4.1. When there are many chemicals which we wish to
`retain in the sample (such as blood), the cost of the necessary dialysate fluid may
`be very large. If a low concentration of certain dialyzable compounds is ultimately
`needed in the sample, relatively larger volumes of dialysate fluid must be used, for
`example, 6 I of phosphate buffer to dialyze 50 ml of sample (Example 4.1 ). This is
`necessary so that the concentration in the dialysate fluid will remain very small
`and there will always be a diffusive driving force. Dialysis is essentially a diffusion(cid:173)
`controlled process.
`Ultrafiltration is based upon the ability of a membrane, under a hydrostatic
`pressure head, to reject relatively high molecular weight components while pas(cid:173)
`sing both solvent and low molecular weight solutes. Thus, while dialysis generally
`removes low molecular weight molecules and ions from the original solution
`volume, ultrafiltration concentrates the original protein solution by removing
`much solvent as well as small solutes.
`With ultrafiltration, the fluxes of solvent and of solute (protein) are often
`reasonably represented by
`
`JV 1 (solvent)= LA!!p- a !in)
`JV 2 (solute)~ Cz(l - a)JV 1 + P !1C2
`
`(4.9)
`(4.10)
`
`Akermin, Inc.
`Exhibit 1020
`Page 3
`
`

`

`188 BIOCHEMICAL ENGINEERING FUNDAMENTALS
`
`Both microencapsulation methods have the potential of offering a very large
`surface area (for example, 2500 cm2 per millimeter of enzyme solution) and the
`possibility of added specificity: the membrane can be made in some cases to admit
`some substrates selectively and exclude others. In principle these methods should
`be applicable to a large variety of enzymes. However, the membrane is a
`significant mass-transfer barrier, so that the "effectiveness factor" for the enzymes
`may be quite small. Also, these techniques are not applicable when the size of the
`substrate molecule approaches that of the enzyme.
`We have already discussed (Sec. 4.2) how semipermeable-membr-ane-filtr-at-ion---(cid:173)
`devices can be used to contain enzyme while allowing interchange of smaller
`molecules with a neighboring solution. A continuous flow ultrafiltration
`concept illustrated schematically in Fig. 4.24, also contains the enzyme as in
`microencapsulation. The surface areas separating the two solutions are substanti-
`ally lower when ultrafiltration is used, and shear denaturation may occur. The
`mass-transfer rates available through membranes are small and may limit the over-
`all rate. However, almost any enzyme or combination of enzymes can be im(cid:173)
`mobilized in this way. It is advantageous when the substrate has very high
`molecular weight or is insoluble, situations where polymer-bound enzymes
`typically may have a small efficiency. Also, the semipermeable membrane will not
`permit relatively large product molecules from polymer-hydrolysis reactions to
`escape from the enzyme solution. This provides an interesting method of control-
`ling the molecular-weight distribution of the products which ultimately leave the
`reactor.
`In Sec. 4.6, we shall return to immobilized enzymes and examine some of their
`present and possible future applications. In current technology, however, enzymes
`in solution enjoy far greater use, as outlined in the next two sections.
`
`Substrate
`
`Enzyme and retentate
`
`1
`
`~--- ----
`-:-::::=..-_ ·- Enzyme-substrate-
`Reactor =---===--: ·_ :-
`product
`
`Ultrafiltration
`unit
`
`Membrane
`
`Pump
`
`Filtrate
`containing
`product
`
`Figure 4.24 Enzyme entrapment on
`a macroscale. An ultrafiltration mem(cid:173)
`brane is used to retain enzyme and
`other large molecules in the reactor.
`
`I
`
`Akermin, Inc.
`Exhibit 1020
`Page 4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket